XPH - SPDR Pharmaceuticals ETF contains 42 holdings. The top holdings include RPRX, ELAN, PFE, MRK, VTRS
Name | Weight |
---|---|
3.87% | |
3.84% | |
![]() | 3.84% |
3.81% | |
![]() | 3.76% |
3.73% | |
3.71% | |
3.70% | |
3.68% | |
3.64% | |
![]() | 3.63% |
3.62% | |
3.56% | |
3.53% | |
![]() | 3.48% |
3.32% | |
2.86% | |
2.46% | |
2.32% | |
2.28% | |
2.19% | |
2.09% | |
2.05% | |
1.94% | |
1.93% | |
![]() | 1.84% |
1.77% | |
![]() | 1.73% |
1.64% | |
1.63% |
Sector | Weight |
---|---|
Health Care | 99.77% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
IHE | 84.40% | $551.02M | 0.39% | |
FBT | 84.34% | $1.02B | 0.54% | |
IBB | 83.42% | $5.37B | 0.45% | |
PBE | 82.81% | $226.91M | 0.58% | |
XBI | 79.27% | $4.81B | 0.35% | |
BBH | 79.19% | $339.54M | 0.35% | |
VHT | 79.04% | $15.34B | 0.09% | |
FXH | 78.84% | $891.22M | 0.62% | |
FHLC | 78.56% | $2.43B | 0.084% | |
PINK | 77.11% | $130.30M | 0.5% | |
MOAT | 76.27% | $12.88B | 0.47% | |
DGRO | 76.22% | $32.39B | 0.08% | |
IYH | 75.92% | $2.72B | 0.39% | |
DSTL | 75.87% | $1.81B | 0.39% | |
RSPH | 75.86% | $721.17M | 0.4% | |
RSP | 75.43% | $73.89B | 0.2% | |
IWD | 75.32% | $62.61B | 0.19% | |
SCHV | 75.31% | $12.78B | 0.04% | |
DLN | 75.11% | $5.07B | 0.28% | |
VONV | 75.10% | $12.79B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IQV | 67.25% | $28.64B | -24.57% | 0.00% |
RITM | 64.76% | $6.23B | +6.33% | 8.54% |
A | 64.69% | $35.27B | -5.08% | 0.80% |
DD | 64.60% | $31.86B | -5.67% | 2.11% |
AVNT | 64.47% | $3.20B | -19.83% | 3.13% |
NDSN | 64.40% | $12.61B | -5.14% | 1.41% |
BN | 64.05% | $105.41B | +42.26% | 0.54% |
BNT | 62.53% | $12.84B | +42.16% | 0.00% |
TECH | 62.47% | $8.53B | -28.75% | 0.60% |
MTD | 62.46% | $25.69B | -8.98% | 0.00% |
AMRX | 62.36% | $2.63B | +15.72% | 0.00% |
NLY | 62.31% | $11.99B | -0.60% | 13.70% |
LIN | 62.30% | $221.40B | +8.15% | 1.24% |
PFG | 62.27% | $18.29B | -2.72% | 3.65% |
ITW | 61.90% | $76.80B | +9.13% | 2.31% |
BLK | 61.72% | $171.05B | +33.85% | 1.88% |
TRU | 61.43% | $18.53B | +20.18% | 0.47% |
FTV | 61.43% | $17.99B | -6.03% | 0.61% |
TXT | 61.40% | $15.39B | -3.39% | 0.09% |
DCI | 61.35% | $8.35B | -0.17% | 1.56% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
TAIL | -57.37% | $94.86M | 0.59% | |
VIXY | -54.65% | $184.73M | 0.85% | |
BTAL | -40.10% | $315.93M | 1.43% | |
IVOL | -34.05% | $342.69M | 1.02% | |
FTSD | -19.55% | $233.11M | 0.25% | |
SHYM | -17.47% | $355.86M | 0.35% | |
XONE | -17.44% | $628.85M | 0.03% | |
SPTS | -14.62% | $5.77B | 0.03% | |
FXY | -14.51% | $802.69M | 0.4% | |
TPMN | -14.01% | $31.06M | 0.65% | |
CLIP | -12.44% | $1.55B | 0.07% | |
ULST | -12.43% | $592.38M | 0.2% | |
SCHO | -11.66% | $10.98B | 0.03% | |
XHLF | -11.10% | $1.73B | 0.03% | |
IBTH | -10.92% | $1.62B | 0.07% | |
UTWO | -10.16% | $376.33M | 0.15% | |
BIL | -9.78% | $41.93B | 0.1356% | |
BILS | -9.73% | $3.80B | 0.1356% | |
VGSH | -9.69% | $22.68B | 0.03% | |
TBLL | -8.98% | $2.12B | 0.08% |
Name | Correlation | AUM | Expense Ratio | |
---|---|---|---|---|
VGIT | 0.04% | $31.63B | 0.04% | |
CGSM | -0.09% | $716.74M | 0.25% | |
CTA | 0.48% | $1.08B | 0.76% | |
JMST | -0.64% | $4.09B | 0.18% | |
WEAT | 0.70% | $123.28M | 0.28% | |
CANE | -0.91% | $11.14M | 0.29% | |
SHY | 1.15% | $23.54B | 0.15% | |
IBTL | 1.26% | $381.26M | 0.07% | |
SHV | 1.31% | $20.59B | 0.15% | |
AGZD | 1.33% | $98.56M | 0.23% | |
IBTF | 1.37% | $1.98B | 0.07% | |
UNG | -1.38% | $375.27M | 1.06% | |
SMB | -1.39% | $276.62M | 0.07% | |
IBTK | -1.46% | $445.94M | 0.07% | |
SPTI | 1.49% | $8.68B | 0.03% | |
LDUR | -1.53% | $922.12M | 0.5% | |
SCHR | 1.73% | $10.79B | 0.03% | |
VTIP | 1.77% | $15.15B | 0.03% | |
SHYD | 1.98% | $331.91M | 0.35% | |
BWX | -2.19% | $1.53B | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SRRK | -0.13% | $3.62B | +326.82% | 0.00% |
CREG | 0.41% | $5.91M | -76.05% | 0.00% |
BTCT | -1.02% | $28.19M | +79.43% | 0.00% |
MKTX | 1.21% | $8.21B | +2.36% | 1.37% |
NEUE | -1.74% | $60.71M | +34.39% | 0.00% |
ZCMD | 2.02% | $28.54M | -8.87% | 0.00% |
K | -2.24% | $27.64B | +40.17% | 2.86% |
STG | -2.70% | $38.79M | -3.01% | 0.00% |
CYCN | 2.70% | $11.40M | +5.03% | 0.00% |
AGL | 2.82% | $956.23M | -62.44% | 0.00% |
AQB | -2.88% | $3.04M | -56.34% | 0.00% |
CIG.C | 2.96% | $2.68B | +23.72% | 0.00% |
CBOE | -3.35% | $24.55B | +38.09% | 1.08% |
PSQH | 3.35% | $105.65M | -40.36% | 0.00% |
RLMD | 3.44% | $22.24M | -84.63% | 0.00% |
DFDV | -3.49% | $363.21M | +2,422.23% | 0.00% |
CPSH | 3.52% | $36.02M | +47.62% | 0.00% |
PULM | 3.61% | $23.52M | +206.67% | 0.00% |
RLX | 3.78% | $2.06B | +24.86% | 0.44% |
FUBO | 3.78% | $1.19B | +173.23% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VSA | -8.80% | $8.59M | -17.17% | 0.00% |
AIFU | -8.61% | $17.40M | +87.81% | 0.00% |
VHC | -6.77% | $69.05M | +176.10% | 0.00% |
VSTA | -5.63% | $325.62M | +30.97% | 0.00% |
HUSA | -4.47% | $20.99M | -8.33% | 0.00% |
LITB | -3.96% | $24.26M | -71.62% | 0.00% |
DFDV | -3.49% | $363.21M | +2,422.23% | 0.00% |
CBOE | -3.35% | $24.55B | +38.09% | 1.08% |
AQB | -2.88% | $3.04M | -56.34% | 0.00% |
STG | -2.70% | $38.79M | -3.01% | 0.00% |
K | -2.24% | $27.64B | +40.17% | 2.86% |
NEUE | -1.74% | $60.71M | +34.39% | 0.00% |
BTCT | -1.02% | $28.19M | +79.43% | 0.00% |
SRRK | -0.13% | $3.62B | +326.82% | 0.00% |
CREG | 0.41% | $5.91M | -76.05% | 0.00% |
MKTX | 1.21% | $8.21B | +2.36% | 1.37% |
ZCMD | 2.02% | $28.54M | -8.87% | 0.00% |
CYCN | 2.70% | $11.40M | +5.03% | 0.00% |
AGL | 2.82% | $956.23M | -62.44% | 0.00% |
CIG.C | 2.96% | $2.68B | +23.72% | 0.00% |
SeekingAlpha
The U.S. administration has decided to delay its self-imposed deadline for implementing reciprocal tariffs until August 1.
SeekingAlpha
Everything You Need To Know As We Near The End Of The U.S. 90-Day Tariff Pause
SeekingAlpha
With high-growth companies consistently delivering superior profit margins, the traditional tradeoff between growth and value may now be irrelevant.
SeekingAlpha
Who Will Benefit From Deregulation?
SeekingAlpha
U.S. Pharma's Innovation Capacity Threatened By Trump Tariff Uncertainty
SeekingAlpha
As we approach the midpoint of 2025, volatility is defining the investment landscape. Read more here.